These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20268746)

  • 1. [A case of kala-azar treated with a new antimony].
    NAUSSAC ; PELLERAT ; GONNET L
    Lyon Med; 1947 May; 177(20):334-9. PubMed ID: 20268746
    [No Abstract]   [Full Text] [Related]  

  • 2. A new sodium antimony gluconate for the treatment of kala-azar.
    DASTIDAR SK
    J Indian Med Assoc; 1945 Sep; 14():298. PubMed ID: 21003768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis of kala-azar. II. Study of Montenegro's test and detection of Leishmania in skin material from patients with kala-azar, before and after antimony treatment].
    Mayrink W; Magalhàes PA; Batista SM; da Costa CA
    Rev Inst Med Trop Sao Paulo; 1971; 13(4):268-71. PubMed ID: 5132387
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of sodium antimony gluconate in mass treatment of kala-azar by the rate of disappearance of Leishman-Donovan bodies.
    HO EA; TAO CY; SUNG SJ
    Chin Med J; 1952; 70(5-6):243-52. PubMed ID: 13127087
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our experience in the treatment of kala-azar].
    de YTURRIAGA E; GONZALEZ BOTELLA S
    Acta Pediatr Esp; 1950 May; 8(89):569-76. PubMed ID: 15418997
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on the treatment of 25 cases of kala-azar with stibatin (sodium antimony gluconate).
    CHOUDHURI RK
    Ind Med Gaz; 1946; 81(4-5):174-6. PubMed ID: 20291436
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Chinese kala-azar with sodium antimony gluconate.
    TUCKMAN E
    J Trop Med Hyg; 1949 Oct; 52(10):199-204. PubMed ID: 15392054
    [No Abstract]   [Full Text] [Related]  

  • 8. Stilbamidine in the treatment of Chinese kala-azar, with especial reference to antimony resistant and antimony hypersensitive cases.
    CHUNG HL; CHOW HK; CHANG A; TSAO YP
    Chin Med J; 1951; 69(3-4):171-84. PubMed ID: 14831172
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agranulocytosis following antimony therapy in kala-azar.
    BRAHMACHARI PN; MAITI CR; KAR CC
    J Indian Med Assoc; 1955 Oct; 25(10):408-10. PubMed ID: 13278551
    [No Abstract]   [Full Text] [Related]  

  • 11. KALA AZAR IN LEBANON. REVIEW OF 72 CASES.
    BITAR J; NACHMAN H
    J Med Liban; 1964; 17():257-68. PubMed ID: 14252819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Two cases of kala-azar treated with glucantime].
    MATOS J; VELASCO JA
    Acta Pediatr Esp; 1955 Nov; 13(155):959-63. PubMed ID: 13301754
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
    SEN GUPTA PC; BHATTACHARYYA B; DAS AK; SANYAL NN
    J Trop Med Hyg; 1952 Sep; 55(9):205-8. PubMed ID: 13011855
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-Kala-Azar dermal leishmaniasis; a report of two typical cases with special reference to result of intensive antimonial therapy.
    TZU-TA C; PANG-MU C; LEE-SHIH L
    Chin Med J; 1953; 71(5):334-42. PubMed ID: 13127100
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
    Pampiglione S; Manson-Bahr PE; La Placa M; Borgatti MA; Musumeci S
    Trans R Soc Trop Med Hyg; 1975; 69(1):60-8. PubMed ID: 1145719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEISHMANIASIS IN THE SUDAN REPUBLIC (26). ELECTROCARDIOGRAPHIC FINDINGS IN SUDANESE KALA-AZAR.
    DEMPSEY JJ
    East Afr Med J; 1965 Apr; 42():131-4. PubMed ID: 14302040
    [No Abstract]   [Full Text] [Related]  

  • 18. KALA-AZAR IN WISCONSIN, CASE REPORT.
    WELSH EC; KANIN HJ
    Am J Gastroenterol; 1963 Dec; 40():615-9. PubMed ID: 14099445
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S ; Kumar J; Singh R; Dwivedi SN
    Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.